Scientific innovations in bionics and biotechnology highlighted

At the ‘Science meets Business’ event at the Bocholt campus of Westfälische Hochschule, researchers demonstrated bionic innovations designed to bridge the gap between science and market application. Key presentations included 3D-printed orthoses utilizing honeycomb structures and tension triangles, which can reduce manufacturing costs by approximately 80 percent. Additionally, new 4D textiles featuring 3D-printed sensors were showcased, offering lightweight solutions for humanoid robotics.

In the biotechnology sector, Ocugen is preparing to present Phase 2 data for its candidate OCU410 at the American Academy of Ophthalmology annual meeting in October. This follows recent activity including a presentation at the Euretina congress and a preliminary approval from the Longevity and Regenerative Therapies Board of the Bahamas for OCU400, a candidate for treating retinitis pigmentosa. The company's market valuation remains sensitive to these upcoming clinical results and regulatory developments.